Login / Signup

The Current Evidence for the Use of Safinamide for the Treatment of Parkinson's Disease.

Giovanni AbbruzzesePaolo BaroneLeonardo LopianoFabrizio Stocchi
Published in: Drug design, development and therapy (2021)
Safinamide is peculiar due to its double mechanism of action. Its benefits in improving motor functions and fluctuations, and some non-motor symptoms, could have a valuable impact on patients' quality of life (QoL), together with its safety profile.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • physical activity